Table 4. Reasons for non-adherence to specified care* (47 hospitals).
| QI | QI descriptor | No. of patients | QI score (%) | Sufficient reasons (%) | Insufficient reasons (%) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Comorbidities | Referral | Patient preference | Errors in data | Other | Unknown | ||||
| QI3 | Radical hysterectomy for stage II adenocarcinoma | 12 | 67.7 | 41.2 | - | 8.3 | 8.3 | 16.7 | 25.0 |
| QI4 | CCRT as the first-line treatment for stage III or IVA | 66 | 55.1 | 63.6 | 6.1 | 12.1 | 3 | 6.1 | 9.1 |
| QI5 | CCRT using cisplatin for stage III or IVA | 15 | 79.9 | 66.7 | - | 6.7 | - | - | 26.6 |
| QI8 | Cystoscope or proctoscope for stage IVA | 14 | 50.0 | 7.1 | 14.3 | 7.1 | 7.1 | 7.1 | 57.1 |
| QI9 | Curative radiation therapy using brachytherapy | 59 | 78.8 | 30.5 | 18.6 | 6.8 | 1.7 | 30.5 | 11.9 |
CCRT, concurrent chemotherapy and radiation therapy; QI, quality indicator.
*Reasons cited for less than 10 patients were excluded from the list.